• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Psychiatric Research Institute
  • UAMS Health
  • Jobs
  • Giving
  • Clinical Care
    • Outpatient Care
      • AR ConnectNow
      • Center for Addiction Services and Treatment
        • Improving Access To Treatment For Opioid Use Disorder
        • MATRIARC
          • Project ECHO
        • Medication and Counseling Treatment
        • Medications To Treat Opioid Use Disorders
        • Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
        • Suboxone Treatment Program
        • Subutex Treatment Program
        • What is Buprenorphine?
        • What Is Methadone?
        • What Is Naltrexone?
        • What Is Vivitrol?
        • Drugs and Addiction
        • New Hybrid Care Program
        • Opioid Use Disorder
      • Child Study Center
        • Dialectical Behavior Therapy
        • Family Resources
          • Handouts for Parents
          • Books
          • Videos
        • Meet the Team – Child Study Center
        • Treatment and Services
      • Psychiatry Clinic in Fayetteville
        • Meet the Team
      • Six Bridges Clinic
      • STRIVE
      • Walker Family Clinic
        • Mental Health Resources
      • Women’s Mental Health Program
        • Peer Support Specialist Services
        • Reproductive Psychiatry Fellowship
        • Substance Use Treatment
        • WMHP Research
        • Women’s Inpatient Unit – 5 North
        • Women’s Mental Health Clinic
        • Women’s Mental Health Program – Fayetteville Branch
      • Odyssey Clinic
        • Northwest Arkansas Schizophrenia Conference 2025 Media
        • Schizophrenia Conference 2024 Media
      • Neuropsychology
    • Inpatient Units
      • Child Diagnostic Unit
        • Child Diagnostic Unit Videos
      • Women’s Inpatient Unit – 5 North
    • Interventional Psychiatry
      • Electroconvulsive Therapy
      • Esketamine
      • Ketamine Infusions
      • SAINT® Neuromodulation System
    • Crisis Stabilization Unit
      • Pulaski County Regional Crisis Stabilization Unit
        • Operation SAVE
  • News
  • PRI Journal
  • Education
  • Research
    • Center for Addiction Research
      • Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
      • What is Vivitrol?
      • Faculty
        • Alison Oliveto, Ph.D
        • Merideth Addicott, Ph.D.
        • Michael Mancino, M.D.
        • Nihit Kumar, M.D.
    • Center for Health Services Research
      • Behavioral Health QUERI
      • Health Services Research and Development Service
      • Rural Outreach Program
        • Rural Outreach Program Team
      • South Central (VISN 16) Mental Illness Research, Education and Clinical Center
      • Center for Health Services Research Faculty and Staff
        • Brandon J. Griffin, Ph.D.
        • Christopher Long, Ph.D.
        • Corey Hayes, Pharm.D., Ph.D., MPH
        • Eva Woodward, Ph.D.
        • Jacob Painter, Pharm.D, Ph.D.
        • Kent D. Hinkson, Ph.D.
        • Leah Tobey, PT, DPT, MBA
        • Marcela Weber, Ph.D.
        • Mary J. Bollinger, MPH, Ph.D.
        • Meghan Breckling, Pharm.D., BCACP
        • Melissa J. Zielinski, Ph.D.
        • Michael Cucciare, Ph.D.
        • Michael Wilson, M.D., Ph.D., FAAEM, FACEP
        • Prasad R. Padala, M.D., M.S., FACHE
        • Rajinder “Sonia” Singh, Ph.D.
        • Rebecca Raciborski, Ph.D.
        • Ronald G. Thompson, Jr., Ph.D., LCSW
        • Sara J. Landes, Ph.D.
        • Traci Abraham, Ph.D.
        • Angie Waliski, Ph.D.
        • Ellen P. Fischer, Ph.D.
        • Geoffrey M. Curran, Ph.D.
        • Greer Sullivan, M.D., M.S.P.H.
        • Jeffrey M. Pyne, M.D.
        • JoAnn Kirchner, M.D.
        • Joy Reeves Pemberton, Ph.D.
        • Karen Drummond, Ph.D.
        • Kristen M. Viverito, Psy.D.
        • Puru Thapa, M.D., M.P.H.
        • Richard R. Owen, M.D.
        • Teresa Hudson, Pharm.D., Ph.D.
        • Teresa L. Kramer, Ph.D.
      • Postdoctoral Fellowship
        • CeMHOR/HSR&D
        • MIRECC
    • Health and the Legal System (HEALS) Lab
      • Projects in the Health and the Legal System (HEALS) Lab
      • Publications and Media
      • About the HEALS Lab
    • Neurodevelopmental Risk and Resilience Program
    • Research Trials
    • Trauma REsilience & Community Collaboration (TRECC)
      • About TRECC
      • Get Involved
      • Research
        • Current Projects
        • Media
        • Selected Research Publications
      • Resources
        • Measures
        • Tools And Tool Kits
    • Helen L. Porter and James T. Dyke Brain Imaging Research Center
  • Patients and Visitors
    • Art of the Psychiatric Research Institute
    • Mental Health Resources
    • Mission And Vision Statements
    • Social Media
    • Map and Directions
    • Job Openings
    • Faculty and Staff
    • Giving
  1. University of Arkansas for Medical Sciences
  2. Psychiatric Research Institute
  3. Past Research Studies

Past Research Studies

Dopamine Enhancement of Fear Extinction Learning in PTSD (DOP)

The goal of this study is to demonstrate the engagement of post-extinction dopamine neurotransmission and downstream acute reorganization of dopaminergic resting-state neural networks as a means of increasing consolidation of generic fear extinction learning in adult women with PTSD.

There are three main stages of this experimental protocol: 1) Assessment, 2) Day 1 fMRI, and 3) Day 2 fMRI. Participants would complete these stages across 2-3 days, depending on participant need. Day 1 fMRI and Day 2 fMRI will always be consecutive days.

During the Assessment stage, participants would undergo a structured clinical interview to assess trauma history and mental health diagnoses. During Day 1 fMRI, participants would complete ~40 min fMRI scan, then ingest a pill (placebo, 100mg L-DOPA, or 200 mg L-DOPA) upon leaving the scanner and wait in a waiting room for ~45 minutes. Participants then complete the Side Effect Checklist to assess any drug-related side effects. The participant would then undergo a 7 min resting-state fMRI scan, which concludes Day 1 fMRI. Participants return ~24 hours later for Day 2 fMRI, in which they first complete the Side Effect Checklist again and then complete a single ~40 minute fMRI scan. All participants will receive compensation.

Eligibility Criteria

  • 21 – 50 years of age
  • Meets criteria for PTSD
  • May or may not have a history of physical or sexual abuse
  • English speaking
  • Medically healthy

Please contact Natalie Morris at NMorris@uams.edu, Nate Jones at NJones@uams.edu or call (501) 420-2653 for more information.

Intrinsic Neuromodulation of Core Affect (INCA)

The purpose of this project is to investigate the brain mechanisms involved in the volitional control of emotion. We will do this by comparing imaging data recorded during opposing goals of a rt-fMRI guided emotion control task (e.g., maximize vs. minimize valence or arousal) to measure changes in areas known to be involved in emotional processing or theorized to be involved in both cognitive control and error processing. In addition, skin conductance will be recorded as an independent measure of emotional arousal.

The current study will consist of two parts: an assessment stage and an MRI scan. Participants may complete study procedures in either one or two days, depending on availability. In the assessment stage, participants will complete a structured clinical interview and a series of questionnaires (see Assessments section). In the scan stage, participants will undergo an MRI scan lasting ~1 hour. All participants will receive compensation.

Eligibility Criteria

  • 18 – 65 years of age
  • Right-handed
  • English speaking
  • Native-born American citizen
  • Medically healthy
  • Negative urine drug screen on day of consent and MRI scan day

Please contact Natalie Morris at NMorris@uams.edu, Nate Jones at NJones@uams.edu or call (501) 420-2653 for more information.

Real-time fMRI and Neurofeedback of Brain Networks Mediating Trauma Memory Recall in PTSD (RPEP)

The purpose of this study is to identify how the brain performs while recalling stressful or traumatic experiences. Participants in this study would be asked to complete interviews and questionnaires and an MRI scan. Participation would involve completion of interviews and questionnaires related to a possible history of trauma, mental health history, and physical health history, and completion of an MRI scan. Participation would require two 3-hour visits to UAMS, taking ~6 hours to complete. Compensation will be provided.

Eligibility Criteria

  • Female
  • 21-50 years of age
  • With our without a history of physical or sexual assault
  • No internal metal
  • No major medical conditions

Please contact Natalie Morris at NMorris@uams.edu, Nate Jones at NJones@uams.edu or call (501) 420-2653 for more information.

Psychiatric Research Institute LogoPsychiatric Research InstitutePsychiatric Research Institute
Mailing Address: 4224 Shuffield Drive, Little Rock, AR 72205
Phone: (501) 526-8100
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement

© 2025 University of Arkansas for Medical Sciences